Invex Therapeutics rolls-out Evolve phase III trial for drug Presendin in IIH patients
November 27, 2022
0ASX:IXC
Watch the video above for detailed insights and analysis.
Video Details
Featured Companies: ASX:IXC
Recorded: November 27, 2022
Stay Ahead
Get the latest market insights and analysis delivered to your inbox.